Penumbra, Inc. to Present at the William Blair 41st Annual Growth Stock Virtual Conference
Penumbra, Inc. (NYSE: PEN) will present at the William Blair 41st Annual Growth Stock Virtual Conference on June 1, 2021, at 4:20 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Penumbra, Inc. (NYSE: PEN) will present at the William Blair 41st Annual Growth Stock Virtual Conference on June 1, 2021, at 4:20 PM ET. The presentation can be accessed via the investor section of their website, with a recorded webcast available for two weeks post-event.
Based in Alameda, California, Penumbra specializes in innovative healthcare therapies and markets its products across the U.S., Europe, Canada, and Australia, targeting unmet medical needs.
Details
News Market Reaction – PEN
The recorded move for PEN in the trading session of this news was -1.77%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALAMEDA, Calif., May 18, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair 41st Annual Growth Stock Virtual Conference on Tuesday, June 1, 2021.
Event: William Blair 41st Annual Growth Stock Virtual Conference
Date: Tuesday, June 1, 2021
Time: 4:20pm ET / 1:20pm PT
A webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the United States, most of Europe, Canada and Australia, and through distributors in select international markets. The Penumbra logo is a trademark of Penumbra, Inc. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.
Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-william-blair-41st-annual-growth-stock-virtual-conference-301293301.html
SOURCE Penumbra, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.